Pictet Asset Management
ACAD icon

Pictet Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Pictet Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.7M Buy
2,026,044
+478,941
+31% +$11.4M 0.05% 331
2025
Q4 		$41.5M Buy
1,547,103
+84,055
+6% +$2.01M 0.04% 359
2025
Q3 		$31.2M Sell
1,463,048
-121,486
-8% -$2.87M 0.03% 425
2025
Q2 		$34.4M Buy
1,584,534
+1,149,578
+264% +$21.4M 0.04% 387
2025
Q1 		$7.42M Sell
434,956
-32,487
-7% -$590K 0.01% 728
2024
Q4 		$8.58M Sell
467,443
-37,281
-7% -$602K 0.01% 704
2024
Q3 		$7.92M Sell
504,724
-7,966
-2% -$133K 0.01% 714
2024
Q2 		$8.33M Sell
512,690
-795,068
-61% -$12.8M 0.01% 669
2024
Q1 		$24M Sell
1,307,758
-153,474
-11% -$3.8M 0.03% 460
2023
Q4 		$45.8M Buy
1,461,232
+109,635
+8% +$2.62M 0.05% 326
2023
Q3 		$28.2M Buy
+1,351,597
New +$36.7M 0.03% 384

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pictet Asset Management's ACAD Position: Q1 2026 in Review

Pictet Asset Management increased its Acadia Pharmaceuticals (ACAD) stake by 31% in Q1 2026, buying an estimated $11.4M and bringing the position to 2,026,044 shares worth $44.7M. The position accounts for 0.05% of the portfolio, ranked #331.

Pictet Asset Management first reported a position in ACAD in Q3 2023 and has held it in 11 quarters since. The position peaked at $45.8M in Q4 2023. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Pictet Asset Management held 2,026,044 shares of Acadia Pharmaceuticals worth $44.7M as of Q1 2026.
  • Pictet Asset Management bought 478,941 Acadia Pharmaceuticals shares in Q1 2026, an estimated $11.4M.
  • Acadia Pharmaceuticals made up 0.05% of Pictet Asset Management's portfolio in Q1 2026, its #331 holding.
  • Pictet Asset Management first reported a position in Acadia Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Acadia Pharmaceuticals position peaked at $45.8M in Q4 2023.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.